Coronavirus Drug Discovery 2022
DOI: 10.1016/b978-0-323-95578-2.00016-9
|View full text |Cite
|
Sign up to set email alerts
|

Dietary polyphenols as therapeutic agents to combat COVID-19

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 41 publications
0
2
0
Order By: Relevance
“…), which shows that at least one monomer of SARS-CoV-2 spike RBD is in its “up” state [ [26] , [27] , [28] ]. Due to its pivotal role in the infection process, several studies targeted S with small molecules in an attempt to prevent the infection by blocking S-ACE2 binding [ 29 , 30 ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…), which shows that at least one monomer of SARS-CoV-2 spike RBD is in its “up” state [ [26] , [27] , [28] ]. Due to its pivotal role in the infection process, several studies targeted S with small molecules in an attempt to prevent the infection by blocking S-ACE2 binding [ 29 , 30 ].…”
Section: Introductionmentioning
confidence: 99%
“…Sarfraz et al reviewed the studied polyphenol compounds that show potential therapeutic efficacy against SAR-CoV and SARS-CoV-2 proteins, including the spike protein. They reported Naringenin, Epigallocatechin gallate (EGCG), and Curcumin as potential interest for the SARS-CoV-2 spike [ 30 ]. Singh et al studied plant-based bioactive compounds as inhibitors of the spike using computational methods.…”
Section: Introductionmentioning
confidence: 99%